Forte Biosciences Inc

Market Cap

$394M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$16.52-$7.09 (-30.03%)

Jun 5, 2026

52W High $35.5352W Low $9.45

Company Details

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmu...

CEO

—

IPO Date

Apr 13, 2017

Website

www.fortebiorx.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$76M

EPS (Diluted)

Free Cash Flow

-$59M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 11, 2026

FY 2025

Mar 31, 2026

Q4 2025

Mar 31, 2026

$0-100.0%

Q3 2025

Nov 14, 2025

Q2 2025

Aug 14, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee